Ra Capital Management, L.P. Kal Vista Pharmaceuticals, Inc. Transaction History

Ra Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.16 - $15.1 $15.8 Million - $29.1 Million	-1,930,322 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$23.12 - $29.91 $36.5 Million - $47.3 Million	1,580,322 Added 451.52%	1,930,322 $46.3 Million
Q1 2021 May 17, 2021	BUY	$14.69 - $42.57 $5.14 Million - $14.9 Million	350,000 New	350,000 $8.99 Million
Q2 2019 Aug 14, 2019	SELL	$18.44 - $30.89 $26.6 Million - $44.5 Million	-1,441,070 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$6.8 - $13.54 $5.78 Million - $11.5 Million	850,000 Added 143.81%	1,441,070 $14.1 Million
Q3 2017 Nov 14, 2017	BUY	$5.84 - $8.88 $3.45 Million - $5.25 Million	591,070	591,070 $4.35 Million

121

47.7M

71.8K

26.3K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $304M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.